Profile
Peter Hudson is the founder of Avipep Pty Ltd., where he holds the title of Chief Scientific Officer starting in 2012.
Avipep Pty Ltd.
was founded in 2005.
Dr. Hudson is also the founder of Evogenix Ltd.
Currently, Dr. Hudson is the Co-Chairman of the International Human Proteomics Antibody Initiative.
In the past, he worked as the Scientific Director at the Cooperative Research Centre for Diagnostics.
Peter Hudson active positions
| Companies | Position | Start |
|---|---|---|
Avipep Pty Ltd.
 Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Founder | 01/01/2005 |
| International Human Proteomics Antibody Initiative | Chairman | 17/05/2010 |
Former positions of Peter Hudson
| Companies | Position | End |
|---|---|---|
Evogenix Ltd.
 Evogenix Ltd. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing antibody therapeutic products. It operates in Australia and the United States. | Founder | - |
Cooperative Research Centre for Diagnostics
 Cooperative Research Centre for Diagnostics Medical/Nursing ServicesHealth Services The Cooperative Research Centre for Diagnostics develops novel diagnostic technologies. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Health Technology |
| International Human Proteomics Antibody Initiative | |
Cooperative Research Centre for Diagnostics
Cooperative Research Centre for Diagnostics Medical/Nursing ServicesHealth Services The Cooperative Research Centre for Diagnostics develops novel diagnostic technologies. | Health Services |
Evogenix Ltd.
Evogenix Ltd. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing antibody therapeutic products. It operates in Australia and the United States. | Health Technology |
- Stock Market
- Insiders
- Peter Hudson
